Transparency Market Research (TMR) has recently announced the addition of a report titled, “Postoperative Pain Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016-2024” to its offering. The report deals with the key growth opportunities, catalysts, deterrents, and trends prevailing in the global market for postoperative pain, along with relevant charts, figures, and statistical data. The report also reveals the major business strategies, market shares, and product offerings of the leading market players.
Recent research shows that a majority of surgical patients do not receive adequate pain relief, resulting in a higher risk of prolonged postoperative pain, physical impairment, and mood disorders. Therefore, the demand for postoperative pain management is likely to step up over the forecast period. Some of the most prominent catalysts of the global market for postoperative pain are increasing awareness about the availability of postoperative pain management techniques, growing geriatric population on a global scale, and increasing incidence of trauma and accidents.
Obtain Report Details: http://www.transparencymarketresearch.com/postoperative-pain-market.html
The adoption of multimodal strategies recommended by experts from various organizations such as the American Society of Anesthesiologists to combat pain might help the market to grow consistently. Also, as the number of surgical operations are increasing, more number of patients are likely to opt for postoperative pain management rather than prescription painkillers. In 2008, almost 15,000 deaths in the U.S. were attributed to overdoses of prescription painkillers, resulting in a shifting preference from prescriptive painkillers to postoperative pain management.
Inadequate pain control is not only inhumane, it also increases mortality and morbidity, suggest studies. As a result, postoperative pain management drugs such as opioids, alpha-2 adrenergic agonists, non-steroidal anti-inflammatory drugs, cholinergic drugs, cyclooxygenase-2-selective, gabapentin-type drugs, and glucocorticoids such as dexamethasone are being used to reduce postoperative pain.
Based on geography, the report segments the global postoperative pain market into Asia Pacific, Latin America, North America, Eastern Europe, the Middle East and Africa, and Western Europe. North America attained the foremost position, driven by growing geriatric population, regulatory practices, and heightened public consciousness about safety and side-effects of operative surgeries.
Fill the form for an exclusive sample of this report:http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15713
Asia Pacific is also likely to advance rapidly, with a massive patient pool, greater number of surgeries, and expeditious growth in healthcare infrastructure driving the growth of this region. India and China are expected to represent a significant chunk of the global market for postoperative pain.
Some of the major companies operating in the global market for postoperative pain are BTG International Ltd., DURECT Corporation, Bayer AG, Grünenthal Group, Novartis AG, A.P. Pharma, Inc., and Pfizer Inc.
Transparency Market Research
90 State Street,
NY – 12207
USA – Canada Toll Free 866-552-3453